In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies-Reference-Cited by-同舟云学术

In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies

Published:2019-03-19 Issue:6 Volume:74 Page:1586-1590
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Rivero-Menendez Olga¹,Cuenca-Estrella Manuel¹,Alastruey-Izquierdo Ana¹^ORCID

Affiliation:

1. Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain; Spanish Network for the Research in Infectious Diseases (REIPI RD16/CIII/0004/0003), Instituto de Salud Carlos III, Madrid, Spain

Funder

Fondo de Investigación Sanitaria

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/6/1586/28666516/dkz078.pdf

Reference21 articles.

1. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study);Alastruey-Izquierdo;Antimicrob Agents Chemother,2013

2. Efflux-mediated antifungal drug resistance;Cannon;Clin Microbiol Rev,2009

3. Antifungal susceptibility profile of cryptic species of Aspergillus;Alastruey-Izquierdo;Mycopathologia,2014